Found: 7
Select item for more details and to access through your institution.
OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PP039 Health Utility Values In Renal Cell Carcinoma: A Systematic Review.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
- Published in:
- PharmacoEconomics, 2015, v. 33, n. 4, p. 381, doi. 10.1007/s40273-014-0245-8
- By:
- Publication type:
- Article
Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Physical and stress-strain properties of wheat ( Triticum aestivum) kernel.
- Published in:
- Journal of the Science of Food & Agriculture, 2011, v. 91, n. 7, p. 1236, doi. 10.1002/jsfa.4305
- By:
- Publication type:
- Article
The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy.
- Published in:
- Global & Regional Health Technology Assessment, 2019, v. 2019, p. 1, doi. 10.1177/2284240319838524
- By:
- Publication type:
- Article
Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain.
- Published in:
- ClinicoEconomics & Outcomes Research, 2012, v. 4, p. 299, doi. 10.2147/CEOR.S34188
- By:
- Publication type:
- Article